Charmaine Kim-Sing

Summary

Affiliation: British Columbia
Country: Canada

Publications

  1. pmc Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Joanne Kotsopoulos
    Breast Cancer Res 14:R42. 2012
  2. pmc Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers
    Reka Pataky
    Cancer Control Research, BC Cancer Agency, 675 W, 10th Ave, Vancouver, BC V5Z 1L3, Canada
    BMC Cancer 13:339. 2013
  3. pmc Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers
    Eitan Friedman
    The Suzanne Levy Gertner Oncogenetics Unit, The Chaim Sheba Medical Center, Tel Hashomer, Israel, and the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Breast Cancer Res 8:R15. 2006
  4. pmc Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy
    A Fuchsia Howard
    School of Population and Public Health, University of British Columbia, Canada
    BMC Womens Health 10:24. 2010
  5. ncbi request reprint Intervention after PSA failure: examination of intervention time and subsequent outcomes from a prospective patient database
    Charmaine Kim-Sing
    Radiation Oncology, BC Cancer Agency, Vancouver BC, Canada
    Int J Radiat Oncol Biol Phys 60:463-9. 2004
  6. ncbi request reprint Hemoglobin levels do not predict biochemical outcome for localized prostate cancer treated with neoadjuvant androgen-suppression therapy and external-beam radiotherapy
    Howard Huaihan Pai
    Radiation Oncology Program, British Columbia Cancer Agency Vancouver Island Centre, Victoria, British Columbia, Canada
    Int J Radiat Oncol Biol Phys 65:990-8. 2006
  7. ncbi request reprint Insulin, macronutrient intake, and physical activity: are potential indicators of insulin resistance associated with mortality from breast cancer?
    Marilyn J Borugian
    Cancer Control Research, British Columbia Cancer Agency, Vancouver, Canada
    Cancer Epidemiol Biomarkers Prev 13:1163-72. 2004
  8. ncbi request reprint Evaluation of the Houston biochemical relapse definition in men treated with prolonged neoadjuvant and adjuvant androgen ablation and assessment of follow-up lead-time bias
    Tom Pickles
    Department of Radiation Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada
    Int J Radiat Oncol Biol Phys 57:11-8. 2003
  9. ncbi request reprint Waist-to-hip ratio and breast cancer mortality
    Marilyn J Borugian
    Cancer Control Research Program, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
    Am J Epidemiol 158:963-8. 2003
  10. ncbi request reprint PSA failure and the risk of death in prostate cancer patients treated with radiotherapy
    Winkle Kwan
    Radiation Therapy Program, Fraser Valley Centre, British Columbia Cancer Agency, Surrey, British Columbia, Canada
    Int J Radiat Oncol Biol Phys 60:1040-6. 2004

Collaborators

Detail Information

Publications25

  1. pmc Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Joanne Kotsopoulos
    Breast Cancer Res 14:R42. 2012
    ..We present an updated analysis of breastfeeding and risk of breast cancer using a large matched sample of BRCA mutation carriers...
  2. pmc Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers
    Reka Pataky
    Cancer Control Research, BC Cancer Agency, 675 W, 10th Ave, Vancouver, BC V5Z 1L3, Canada
    BMC Cancer 13:339. 2013
    ..The purpose of this study was to calculate the cost-effectiveness of MRI screening for breast cancer in BRCA1/2 mutation carriers in a Canadian setting...
  3. pmc Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers
    Eitan Friedman
    The Suzanne Levy Gertner Oncogenetics Unit, The Chaim Sheba Medical Center, Tel Hashomer, Israel, and the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Breast Cancer Res 8:R15. 2006
    ....
  4. pmc Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy
    A Fuchsia Howard
    School of Population and Public Health, University of British Columbia, Canada
    BMC Womens Health 10:24. 2010
    ..Women's perspectives on the timing of these decisions are not well understood. Accordingly, the purpose of this research was to describe how women construct the 'right time' to consider decisions about RRM and RRO...
  5. ncbi request reprint Intervention after PSA failure: examination of intervention time and subsequent outcomes from a prospective patient database
    Charmaine Kim-Sing
    Radiation Oncology, BC Cancer Agency, Vancouver BC, Canada
    Int J Radiat Oncol Biol Phys 60:463-9. 2004
    ..To investigate timing of intervention for solitary biochemical relapse following external beam radiation therapy (EBRT) for localized prostate cancer, and to assess the impact on survival...
  6. ncbi request reprint Hemoglobin levels do not predict biochemical outcome for localized prostate cancer treated with neoadjuvant androgen-suppression therapy and external-beam radiotherapy
    Howard Huaihan Pai
    Radiation Oncology Program, British Columbia Cancer Agency Vancouver Island Centre, Victoria, British Columbia, Canada
    Int J Radiat Oncol Biol Phys 65:990-8. 2006
    ..To investigate whether hemoglobin (Hb) levels affect outcome in men with localized prostate adenocarcinoma (LPA) treated with neoadjuvant androgen-suppression therapy (NAST) and external-beam radiotherapy (EBRT)...
  7. ncbi request reprint Insulin, macronutrient intake, and physical activity: are potential indicators of insulin resistance associated with mortality from breast cancer?
    Marilyn J Borugian
    Cancer Control Research, British Columbia Cancer Agency, Vancouver, Canada
    Cancer Epidemiol Biomarkers Prev 13:1163-72. 2004
    ..8; 95% CI, 1.3-18.1, comparing highest to lowest quartile). Higher dietary protein intake was associated with better survival for all women (relative risk, 0.4; 95% CI, 0.2-0.8, comparing highest to lowest quartile)...
  8. ncbi request reprint Evaluation of the Houston biochemical relapse definition in men treated with prolonged neoadjuvant and adjuvant androgen ablation and assessment of follow-up lead-time bias
    Tom Pickles
    Department of Radiation Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada
    Int J Radiat Oncol Biol Phys 57:11-8. 2003
    ....
  9. ncbi request reprint Waist-to-hip ratio and breast cancer mortality
    Marilyn J Borugian
    Cancer Control Research Program, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
    Am J Epidemiol 158:963-8. 2003
    ..Elevated WHR was confirmed as a predictor of breast cancer mortality, with menopausal status and ER status at diagnosis found to be important modifiers of that relation...
  10. ncbi request reprint PSA failure and the risk of death in prostate cancer patients treated with radiotherapy
    Winkle Kwan
    Radiation Therapy Program, Fraser Valley Centre, British Columbia Cancer Agency, Surrey, British Columbia, Canada
    Int J Radiat Oncol Biol Phys 60:1040-6. 2004
    ..To determine the relationship between prostate-specific antigen (PSA) failure and cause-specific and overall survival in prostate cancer patients treated with radical radiotherapy...
  11. pmc International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers
    Kelly A Metcalfe
    Lawrence S Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada
    Int J Cancer 122:2017-22. 2008
    ..Approximately one-half of women at risk for breast cancer rely on screening alone...
  12. doi request reprint Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group
    Kelly A Metcalfe
    Lawrence Bloomberg Faculty of Nursing, University of Toronto, Canada
    J Clin Oncol 26:1093-7. 2008
    ..To evaluate the rate of prophylactic contralateral mastectomy in an international cohort of women with hereditary breast cancer and to evaluate the predictors of uptake of preventive surgery...
  13. ncbi request reprint Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Joanne Kotsopoulos
    Centre for Research in Women s Health, Women s College Hospital, University of Toronto, Room 750, 790 Bay Street, 7th Floor, Toronto, ON M5G 1N8, Canada
    Breast Cancer Res Treat 105:221-8. 2007
    ..Nonetheless, BRCA mutation carriers opting for a prophylactic oophorectomy as a breast and/or ovarian cancer risk-reducing strategy should complete childbearing prior to age 40 when this prevention modality is most effective...
  14. pmc Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers
    Andrea Eisen
    Sunnybrook Regional Cancer Center, Toronto, Ontario, Canada
    J Natl Cancer Inst 100:1361-7. 2008
    ....
  15. ncbi request reprint Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Steven A Narod
    The Centre for Research on Women s Health, University of Toronto, 790 Bay Street, Toronto, Ontario M5G 1N8, Canada
    J Natl Cancer Inst 94:1773-9. 2002
    ..We examined whether this association is seen in women at high risk of breast cancer because they carry a mutation in one of two breast cancer susceptibility genes, BRCA1 and BRCA2...
  16. ncbi request reprint Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update
    Jacek Gronwald
    Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical Academy, Szczecin, Poland
    Int J Cancer 118:2281-4. 2006
    ..83; 95%CI, 0.24-2.89) but this subgroup was small. In contrast, a strong protective effect of tamoxifen was apparent among women who were premenopausal or who had undergone natural menopause (OR = 0.44; 95% CI, 0.27-0.65)...
  17. ncbi request reprint A comparison of bilateral breast cancers in BRCA carriers
    Jeffrey N Weitzel
    The Centre for Research in Women s Health, 790 Bay Street, Toronto, Ontario, Canada M5G 1N8
    Cancer Epidemiol Biomarkers Prev 14:1534-8. 2005
    ..It is generally believed that the two cancers represent independent events. However, the extent of concordance between the first and second tumors with respect to hormone receptor expression and other pathologic features is unknown...
  18. ncbi request reprint Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers
    Carey A Cullinane
    City of Hope National Medical Center, Duarte, CA, USA
    Int J Cancer 117:988-91. 2005
    ..Among BRCA2 carriers, increasing parity was associated with a significant increase in the risk of breast cancer before age 50 and this increase was greatest in the 2-year period following a pregnancy...
  19. ncbi request reprint Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers
    Andre Nkondjock
    Epidemiology Research Unit, Research Centre, Centre Hospitalier de Universitaire de Montréal, CHUM Hotel Dieu, Montreal, Canada
    Int J Cancer 118:103-7. 2006
    ..These results suggest that among women with BRCA gene mutation, coffee consumption is unlikely to be harmful and that high levels of consumption may in fact be related to reduced breast cancer risk...
  20. pmc Rapid progression of prostate cancer in men with a BRCA2 mutation
    S A Narod
    Women s College Research Institute, 790 Bay Street, 7th Floor, Women s College Hospital, University of Toronto, Toronto, Ontario, Canada
    Br J Cancer 99:371-4. 2008
    ..0 years for men with a BRCA1 mutation, and the difference was highly significant (P<0.01). It may be important to develop targeted chemotherapies to treat prostate cancer in men with a BRCA2 mutation...
  21. ncbi request reprint Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Joanne Kotsopoulos
    Centre for Research in Women s Health, University of Toronto, Women s College Hospital, 790 Bay Street, 7th Floor, Totonto, Ontario M5G 1N8, Canada
    Cancer Causes Control 16:667-74. 2005
    ..46; 95% CI 0.30-0.69). This study implicates early age at menarche as a determinant of breast cancer among women with a BRCA1 mutation...
  22. pmc Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Joanne Kotsopoulos
    Centre for Research in Women s Health, Women s College Hospital, University of Toronto, Toronto, ON, Canada
    Breast Cancer Res 7:R833-43. 2005
    ..We asked whether there is an association between changes in body weight and the risk of breast cancer in women who carry a mutation in either breast cancer susceptibility gene, BRCA1 or BRCA2...
  23. ncbi request reprint Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study
    Andrea Eisen
    Toronto Sunnybrook Regional Cancer Center, Toronto, ON, Canada
    J Clin Oncol 23:7491-6. 2005
    ....
  24. ncbi request reprint Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation
    Amy Finch
    Centre for Research in Women s Health, Toronto Sunnybrook Regional Cancer Center, Toronto, Ontario, Canada
    JAMA 296:185-92. 2006
    ..Women with BRCA1 or BRCA2 mutation are often advised to undergo preventive oophorectomy. The effectiveness of this intervention has not been prospectively evaluated in a large cohort...
  25. ncbi request reprint Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study
    Steven A Narod
    Centre for Research on Women s Health, University of Toronto, Ontario, Canada
    Lancet Oncol 7:402-6. 2006
    ..We aimed to assess whether exposure to ionising radiation through mammography screening was associated with risk of breast cancer in BRCA1 or BRCA2 mutation carriers...